Methyldopa and Maternal condition affecting foetus - a phase IV clinical study of FDA data

Summary:

Maternal condition affecting foetus is reported as a side effect among people who take Methyldopa (methyldopa), especially for people who are 30-39 old, have been taking the drug for < 1 month also take Sertraline, and have Maternal therapy to enhance foetal lung maturity.

The phase IV clinical study analyzes which people have Maternal condition affecting foetus when taking Methyldopa. It is created by eHealthMe based on reports of 6,345 people who have side effects when taking Methyldopa from the FDA, and is updated regularly.

What is Methyldopa?

Methyldopa has active ingredients of methyldopa. It is often used in high blood pressure. eHealthMe is studying from 6,475 Methyldopa users. Check the latest studies of Methyldopa.

What is Maternal condition affecting foetus?

Maternal condition affecting foetus (mother condition affecting baby) is found to be associated with 28 drugs and 114 conditions by eHealthMe. Check the latest studies of Maternal condition affecting foetus.

On Jul, 07, 2026

6,345 people reported to have side effects when taking Methyldopa.
Among them, 17 people (0.27%) have Maternal condition affecting foetus.

Could Methyldopa cause Maternal condition affecting foetus?

Among these 17 people:

How long have people been on Methyldopa when they have Maternal condition affecting foetus? *

What is the age of people who have Maternal condition affecting foetus when taking Methyldopa? *

What are other drugs people take besides Methyldopa? *

Sertraline: 10 people, 58.82%
Acetylsalicylic Acid: 8 people, 47.06%
Nifedipine: 5 people, 29.41%
Allopurinol: 4 people, 23.53%
Aspirin: 4 people, 23.53%
Folic Acid: 4 people, 23.53%
Heparin Sodium: 1 person, 5.88%
Amitriptyline Hydrochloride: 1 person, 5.88%
Betamethasone Dipropionate: 1 person, 5.88%
Calcium Pantothenate: 1 person, 5.88%

What are other side effects people have besides Maternal condition affecting foetus? *

Maternal Exposure During Pregnancy (use of substance during pregnancy): 14 people, 82.35%
Haemoperitoneum (presence of blood in the peritoneal cavity): 13 people, 76.47%
Azotaemia (excess of urea or other nitrogenous compounds in the blood): 13 people, 76.47%
Urinary Tract Infection: 13 people, 76.47%
Abdominal Distension: 13 people, 76.47%
Premature Labor: 11 people, 64.71%
Gestational Hypertension (elevated blood pressure during pregnancy): 8 people, 47.06%
Threatened Labor: 8 people, 47.06%
Premature Delivery: 7 people, 41.18%
Nausea And Vomiting: 6 people, 35.29%

What are the existing conditions these people have? *

Tocolysis (inhibition of uterine contractions): 13 people, 76.47%
Maternal Therapy To Enhance Foetal Lung Maturity: 13 people, 76.47%
Toothaches (tooth pain): 1 person, 5.88%
Gestational Hypertension (elevated blood pressure during pregnancy): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Methyldopa and have Maternal condition affecting foetus?

- Check whether Maternal condition affecting foetus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methyldopa:

Methyldopa (6,475 reports)

Browse all side effects of Methyldopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Maternal condition affecting foetus:

Maternal condition affecting foetus (28 drugs)

Browse all the conditions that are associated with Maternal condition affecting foetus:

Maternal condition affecting foetus (114 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methyldopa (the active ingredients of Methyldopa) and Methyldopa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.